CLEC10A and breast cancer: Analysis of TCGA RNA-seq data from patients with invasive ductal carcinoma (IDC) revealed an upregulation of HML-2 in basal-like breast cancers (which largely comprises those of the TNBC molecular subtype) compared to HER2 overexpressing and luminal tumours.